RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2001; 86(06): 1593-1594
DOI: 10.1055/s-0037-1616776
DOI: 10.1055/s-0037-1616776
Letters to the Editor
A Family History of Type 2 Diabetes Is Associated with Lower Sensitivity to Activated Protein C in Overweight and Obese Premenopausal Women
Weitere Informationen
Publikationsverlauf
Received
13. Februar 2001
Accepted after resubmission
12. September 2001
Publikationsdatum:
12. Dezember 2017 (online)

-
References
- 1 Pierce M, Keen H, Bradley C. Risk of diabetic in offspring of parents with non-insulin-dependent diabetes. Diabetic Medicine 1995; 12: 6-13.
- 2 Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis FK, Mandalaki T, Kyriakidis MK. Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens 2000; 13 1 pt 1 61-5.
- 3 Ripoll L, Mazoyer E, Baudin B, Lacam S, Varsat L, Drouet O. Can high plasma ceruloplasmin levels cause acquired activated protein C resistance?. Thromb Haemost 1998; 79: 449-50.
- 4 Cignarelli M, De Pergola G, Picca G, Sciaraffia M, Pannacciulli N, Tarallo M, Laudadio E, Turrisi V, Giorgino R. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obesity 1996; 20: 809-13.
- 5 De Mitrio V, Marino R, Cicinelli E, Galantino P, Di Bari F, Giannoccaro F, De Pergola G, Lapecorella M, Schonauer S, Schiraldi O. Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C. Blood, Coagulation and Fibrinolysis 2000; 11: 175-82.